Biomarin Pharmaceutical Inc
BMRN
$57.33-2.13 (-3.58%)
Aug 8, 2025, 4:00 PM
Financials
| 52Week High | 94.85 | 52Week Low | 52.93 |
| Beta | 0.34 | Current Ratio Annual | 5.33 |
| Current Ratio Quarterly | 5.56 | Gross Margin TTM | 79.56 |
| Market Cap | 11.01B | Net Profit Margin TTM | 21.45 |
| Operating Margin TTM | 25.33 | Price To Book | 1.83 |
| Price To Earnings TTM | 16.75 | Price To Free Cash Flow TTM | 15.93 |
| Price To Sales TTM | 3.59 | Quick Ratio Annual | 3.29 |
| Quick Ratio Quarterly | 3.60 | Return On Assets TTM | 9.24 |
| Return On Equity TTM | 11.48 | Return On Investment TTM | 10.40 |
| Revenue Growth3Y | 15.62 | Revenue Growth5Y | 10.86 |
| Revenue Growth Quarterly Yoy | 15.92 | Revenue Growth TTMYoy | 18.36 |
| Revenue Per Share TTM | 15.54 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 571 | 89 | 60 | 232 | 176 | 61 | 184.33M | $12.67B |
| Jun 30, 2025 | 254 | 36 | 42 | 98 | 71 | 38 | 19.69M | $953.17M |
| Change | 317(56%) | 53(60%) | 18(30%) | 134(58%) | 105(60%) | 23(38%) | 164.64M(89%) | $11.72B(92%) |